Published in Br J Urol on September 01, 1992
The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol (2004) 2.56
Can urine dipstick testing for urinary tract infection at point of care reduce laboratory workload? J Clin Pathol (2005) 1.37
Re: Screening for bacteriuria in urological patients using reagent strips. Br J Urol (1993) 0.75
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS (1998) 8.88
Taxonomic Relationships of Alcaligenes spp. to Certain Soil Saprophytes and Plant Parasites. J Bacteriol (1940) 7.31
Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother (1999) 4.36
Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet (1985) 2.76
A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol (2000) 2.73
Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci (2001) 2.64
Central venous line sepsis. Anaesthesia (1997) 2.36
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer (2011) 2.28
The time course of visual word recognition as revealed by linear regression analysis of ERP data. Neuroimage (2006) 2.26
An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J Hosp Infect (1990) 2.24
Screening for prostate cancer in the UK. Seems to be creeping in by the back door. BMJ (2001) 2.22
Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med (1998) 2.12
Large inverted duplications are associated with gene amplification. Cell (1986) 2.10
Ambulatory urodynamics. Br J Urol (1996) 2.06
Environmental novelty is signaled by reduction of the hippocampal theta frequency. Hippocampus (2008) 2.01
Therapeutic beds: the Trojan horses of the 1990s? Lancet (1994) 1.96
Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab (2001) 1.95
Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother (2004) 1.85
Use of cephalexin-aztreonam-arabinose agar for selective isolation of Enterococcus faecium. J Clin Microbiol (1994) 1.85
Rapid conventional scheme for biochemical identification of antibiotic resistant enterobacteriaceae isolates from urine. J Clin Pathol (1988) 1.85
MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Oncogene (2003) 1.83
Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies. Eur J Cancer (2010) 1.79
Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet (2000) 1.78
The management of men with acute urinary retention. National Prostatectomy Audit Steering Group. Br J Urol (1998) 1.76
Developing countries have their own characteristic problems with infection control. J Hosp Infect (2004) 1.71
Structure of an inverted duplication formed as a first step in a gene amplification event: implications for a model of gene amplification. EMBO J (1987) 1.68
Use of antibiotic locks to treat colonized central venous catheters. J Antimicrob Chemother (2001) 1.68
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nat Med (1996) 1.68
Tip60 is a nuclear hormone receptor coactivator. J Biol Chem (1999) 1.67
A component-based, distributed object services architecture for a clinical workstation. Proc AMIA Annu Fall Symp (1996) 1.66
Written consent about sexual function in men undergoing transurethral prostatectomy. Br J Urol (1994) 1.65
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study. Br J Cancer (2011) 1.62
Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate (1998) 1.61
Antibiotic prophylaxis in permanent pacemaker implantation: a prospective randomised trial. Br Heart J (1994) 1.60
Isolation of a gene enhancer within an amplified inverted duplication after "expression selection". Proc Natl Acad Sci U S A (1985) 1.58
Respiratory diseases in cyclophosphamide-treated mice. I. Increased virulence of Mycoplasma pulmonis. Infect Immun (1972) 1.55
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Nosocomial infection with microsphere beds. Lancet (1993) 1.52
Bladder function in healthy volunteers: ambulatory monitoring and conventional urodynamic studies. Br J Urol (1994) 1.51
Clinical outcome and quality of life following enterocystoplasty for idiopathic detrusor instability and neurogenic bladder dysfunction. Br J Urol (1995) 1.50
Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol (1995) 1.49
p53 and p53-regulated genes in bladder cancer. Br J Urol (1998) 1.46
Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. J Infect (1994) 1.45
Mucin gene expression in human urothelium and in intestinal segments transposed into the urinary tract. J Urol (2000) 1.45
Nosocomial infection due to enterococci attributed to a fluidized microsphere bed. The value of pyrolysis mass spectrometry. J Hosp Infect (1994) 1.44
Lead toxicosis in 2 dwarf rabbits. Can Vet J (1997) 1.44
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med (2016) 1.41
Ingestion of an unknown alcohol. Ann Emerg Med (1996) 1.40
Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer (1991) 1.39
The effect of prostatectomy on symptom severity and quality of life. Br J Urol (1996) 1.39
Use of a combined right ventricular ejection fraction-oximetry catheter system for coronary bypass surgery. Crit Care Med (1992) 1.38
Significance of Epstein-Barr virus status and post-transplant lymphoproliferative disease in pediatric thoracic transplantation. Pediatr Transplant (1999) 1.38
Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. Mol Endocrinol (2000) 1.38
Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer. Br J Cancer (2001) 1.37
Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening. Br J Cancer (2009) 1.36
Mycobacterium novocastrense sp. nov., a rapidly growing photochromogenic mycobacterium. Int J Syst Bacteriol (1997) 1.36
Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax (2008) 1.36
Nuclear LYRIC/AEG-1 interacts with PLZF and relieves PLZF-mediated repression. Oncogene (2009) 1.33
Rectal, bladder and sexual function after mucosal proctectomy with and without a pelvic reservoir for colitis and polyposis. Br J Surg (1982) 1.33
In vivo gene therapy in young and adult RPE65-/- dogs produces long-term visual improvement. J Hered (2003) 1.30
Evaluation of epidermal growth factor receptors in bladder tumours. Br J Cancer (1987) 1.30
C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value. J Urol (1996) 1.30
A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study. J Urol (2000) 1.27
Primary airway epithelial cell culture from lung transplant recipients. Eur Respir J (2005) 1.23
Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. Br Heart J (1986) 1.22
Statistical problems with 'optimal' thresholds in studies of new prognostic factors in urology. BJU Int (2000) 1.21
FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease. Oncogene (1999) 1.21
Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma. Br J Cancer (2006) 1.19
UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer (2009) 1.18
Transforming growth factor-beta1 up-regulates p15, p21 and p27 and blocks cell cycling in G1 in human prostate epithelium. J Endocrinol (1999) 1.17
Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut (1996) 1.17
ABC medium, a new chromogenic agar for selective isolation of Salmonella spp. J Clin Microbiol (1999) 1.16
Evaluation of chromogenic media for the isolation of vancomycin-resistant enterococci from stool samples. Lett Appl Microbiol (2009) 1.15
Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate. Eur Urol (2004) 1.14
Toward the measurement of primary care. Milbank Mem Fund Q Health Soc (1978) 1.12
Healthy city projects in developing countries: the first evaluation. Health Promot Int (2001) 1.12
Transurethral prostatic resection or laser therapy for men with acute urinary retention: the ClasP randomized trial. J Urol (2001) 1.12
Pyrolysis-mass spectrometry (Py-MS) for the rapid epidemiological typing of clinically significant bacterial pathogens. J Med Microbiol (1990) 1.12
Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. Br J Cancer (2010) 1.12
Assessment of in-flight transmission of SARS--results of contact tracing, Canada. Can Commun Dis Rep (2003) 1.11
Glycopeptide tolerance in bacteria causing endocarditis. J Antimicrob Chemother (1999) 1.11
Case-control study of waterborne giardiasis in Reno, Nevada. Am J Epidemiol (1985) 1.09
Changes in the intensity and pleasantness of human vaginal odors during the menstrual cycle. Science (1975) 1.09
Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev (2003) 1.08
Effect of hypertension on myocardial rupture after acute myocardial infarction. Chest (1977) 1.08
Transcutaneous electrical nerve stimulation and temporary S3 neuromodulation in idiopathic detrusor instability. J Urol (1996) 1.08
Radial or ulnar artery laceration. Repair or ligate? Arch Surg (1993) 1.08
Can I have a quick word? Early electrophysiological manifestations of psycholinguistic processes revealed by event-related regression analysis of the EEG. Biol Psychol (2008) 1.08
Tip60 is a co-activator specific for class I nuclear hormone receptors. J Biol Chem (2001) 1.07
A crossover randomized trial of transcutaneous electrical nerve stimulation and oxybutynin in patients with detrusor instability. J Urol (2001) 1.07
The National Prostatectomy Audit: the clinical management of patients during hospital admission. Br J Urol (1995) 1.07
p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol (1992) 1.06
Studies of membrane fusion. I. Paramyxovirus-induced cell fusion, a scanning electron-microscope study. J Cell Sci (1977) 1.06
Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B. Mol Pharmacol (1998) 1.05
P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia. Br J Urol (1992) 1.05